Search results for "Psychotic Disorder"
showing 3 items of 173 documents
ReMindCare, an app for daily clinical practice in patients with first episode psychosis: A pragmatic real-world study protocol.
2021
[EN] Aim Despite the potential benefits of e-health interventions for patients with psychosis, the integration of these applications into the clinical workflow and analysis of their long-term effects still face significant challenges. To address these issues, we developed the ReMindCare app. This app aims to improve the treatment quality for patients with psychosis. We chose to study the app in real world and pragmatic manner to ensure results will be generalizable. Methods This is a naturalistic empirical study of patients in a first episode of psychosis programme. The app was purpose-designed based on two previous studies, and it offers the following assessments: (a) three daily questions…
SCHIZOFRENIA E ADATTAMENTO NEL CASO DI BEATRICE
2017
This paper is focused on the outcomes of psychotic functioning and, in particular, on individual and contextual elements that could influence the level of adjustment of a patient with schizophrenia. The case of Beatrice, who was diagnosed with schizophrenia at the age of 23, is analyzed using the personal diary that she herself compiled over about fifty years, in which she documented the fundamental events of her life. In the story of B. certain protective factors were highlighted, which enabled B. to have a good quality of life: effective pharmacological therapy with no side-effects, awareness of the pathology, the capacity to build satisfying interpersonal relationships and her religious …
Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with …
2019
ObjectiveOur aim was to summarize the efficacy and safety of atomoxetine, amphetamines, and methylphenidate in schizophrenia.MethodsWe undertook a systematic review, searching PubMed/Scopus/Clinicaltrials.gov for double-blind, randomized, placebo-controlled studies of psychostimulants or atomoxetine in schizophrenia published up to 1 January 2017. A meta-analysis of outcomes reported in two or more studies is presented.ResultsWe included 22 studies investigating therapeutic effects of stimulants (k=14) or measuring symptomatic worsening/relapse prediction after stimulant challenge (k=6). Six studies of these two groups plus one additional study investigated biological effects of psychostimu…